UNSPSC 51372016: Nalbuphine

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2T84IQI2K. European Medicines Agency schedules Nalbuphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09137MIG. Nalbuphine generally arises in the molecular formula C21H27NO4.

UNSPSC 51372016 Nalbuphine is a Commodity code that captures procurement of opioid antagonists and related pharmaceutical products by state and local health agencies. State and local governments buy nalbuphine and naloxone—opioid antagonists used in emergency response and community health initiatives—through this code. Recent solicitations show state health agencies and county health departments procuring naloxone and drug deactivation systems as part of overdose-prevention and substance-abuse programs, with requirements for quarterly or ongoing deliveries to designated health facilities, fixed pricing models, and compliance with federal drug supply chain security standards and good manufacturing practices.

Activity under the code centers on state health departments, county health departments, and cooperative purchasing alliances. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building, due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 as preliminary market research into direct-to-manufacturer prescription programs, which may eventually inform pharmaceutical procurement including nalbuphine and related products. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. Recent activity appears concentrated in the Southeast (Florida) and Midwest (Minnesota, with interstate reach into Oregon), with exploratory procurement in Texas. The code shows moderate recent activity, with issuing bodies spanning county health departments, state health agencies, and multi-state cooperative purchasing vehicles.